Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Alaska for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Alaska only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Alaska (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Laura Luebke (NPI 1669742193)

Field	Value
Entity Type	Individual
Organization	Laura Luebke
Address	3801 Lake Otis Pkwy Ste 300
City	Anchorage
State	AK
ZIP	99508
Taxonomy	Medical Physician Assistant
NPI Enumerated	December 30, 2011

Payer Source	Total Paid
Medicare	$428.6K
Medicaid	$0

Key Findings

This provider’s lifetime Medicare receipts total $428.6K while there is no Medicaid billing on file, so the practice operates effectively as single‑payer (Medicare) in the available claims data. The NPI was enumerated 2011-12-30 (~15 years ago), indicating a stable enrollment period across roughly a decade and a half.

Revenue is highly concentrated: the precomputed top‑3 Medicare codes account for 91.2% of this provider’s total Medicare revenue, driven primarily by J3111, J0897, and 99214. Those three codes individually account for $228.5K (53.1%), $114.5K (26.6%), and $49.3K (11.5%) of Medicare revenue respectively, showing very heavy dependence on a small set of services.

The code mix points to a service line centered on in‑office biologic injections for bone health plus evaluation-and-management visits: J3111 (romosozumab) and J0897 (denosumab) dominate revenue, while 99214 represents the main office visit level billed. This pattern is consistent with an office-based musculoskeletal or osteoporosis treatment practice that administers frequent injectable therapies and manages patients in clinic visits.

J3111 activity is notable nationally: the provider ranks #186 of 970 providers nationally for J3111 (81th percentile; typical, unremarkable volume for this code), signaling above‑median participation in romosozumab administration but not an outlier. J0897 likewise shows solid national participation at rank #2129 of 10057 (79th percentile; typical, unremarkable volume for this code), indicating respectable denosumab utilization versus peers.

The provider’s use of E/M code 99214 is relatively high versus national peers, with a rank of #41046 of 479517 (91th percentile; typical, unremarkable volume for this code), which suggests a comparatively elevated volume of moderate-complexity established patient visits in addition to the injection services. This supports the view of sustained office-based patient management capacity rather than isolated procedural billing.

Operationally, the top drug codes are driven by very high claim counts at modest average paid amounts: for example, J3111 shows 28.6K claims at $8 avg paid/claim producing $228.5K in revenue, and J0897 shows 6.4K claims at $18 avg paid/claim producing $114.5K. That combination of large claim volumes with low per‑claim averages implies a workflow oriented to frequent, repeat administrations rather than a few high‑dollar per‑claim events.

Ancillary services and testing are present but contribute only marginally to Medicare revenue: examples include 82306 ($3.9K, 0.9%), 80053 ($3K, 0.7%), and 36415 ($2.8K, 0.6%). These smaller lab and procedural codes indicate routine supportive testing and phlebotomy consistent with ongoing management of a medically complex outpatient population, but they are minor revenue drivers compared with the biologic injections.

The concentrated reliance on a narrow set of injectable biologic codes (top 3 = 91.2% of Medicare revenue) makes the practice’s Medicare revenue stream sensitive to changes in utilization, coverage policy, or reimbursement for those specific agents; monitoring payer policy and utilization authorizations for J3111 and J0897 would be particularly relevant for payers and network managers.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

20 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J3111	Injection, romosozumab-aqqg, 1 mg	28,560	$10	$228.5K
J0897	Injection, denosumab, 1 mg	6,360	$20	$114.5K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	550	$90	$49.3K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	140	$70	$9.6K
82306	The lab analyst measures the vitamin D level, typically on a serum specimen. This analyte, commonly known as vitamin D, is not really a vitamin, but is an important steroid hormone that is produced…	130	$30	$3.9K
80053	The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel.	300	$10	$3K
36415	In this procedure, the provider inserts a needle into a vein to collect a blood sample.	350	$10	$2.8K
96372	A therapeutic, prophylactic, or diagnostic substance (a fluid, a drug, etc.) is injected via intramuscular or subcutaneous route into the patient's body. The procedure is performed by the physician…	240	$10	$2.7K
99215	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the…	20	$130	$2.4K
99203	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the provider…	20	$90	$2K

Showing 1–10 of 20

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 20 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Alaska Distribution

Laura Luebke — 5 of 20 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Alaska

Full comparison — all codes billed, vs. state median

20 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J3111	2	10	22,470	$10	$192.9K
J0897	8	30	2,700	$20	$82.7K
99214	50	1,210	90	$100	$16.2K
99215	316	400	40	$150	$11K
99213	361	1,290	70	$70	$8.5K
90694	48	60	50	$70	$6.5K
99204	352	460	30	$140	$6.1K
99203	288	430	40	$90	$4.5K
G0008	92	140	40	$30	$4.4K
80053	11	190	70	$10	$1.4K

Showing 1–10 of 20

Related Providers

Other providers that share a Tax Identification Number (TIN) with Laura Luebke, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Orthoalaska, LLC	AK	Orthopaedic Surgery Physician	$0	$5.8M
John Botson	AK	Rheumatology Physician	$1.8M	$0
Bryan Haughom	AK	Orthopaedic Surgery Physician	$525.6K	$0
Ryan Ragle	AK	Rheumatology Physician	$413.8K	$0
James Eule	AK	Orthopaedic Surgery of the Spine Physician	$400.6K	$0
Mark Flanum	AK	Orthopaedic Surgery of the Spine Physician	$270K	$0
Derrick Foge	AK	Orthopaedic Surgery of the Spine Physician	$268.1K	$0
Thomas Paynter	AK	Orthopaedic Surgery Physician	$260.9K	$0
Curtis Mina	AK	Orthopaedic Surgery of the Spine Physician	$236.4K	$0
Tucker Drury	AK	Orthopaedic Surgery Physician	$228.8K	$0

Laura Luebke — Billing Profile & Reimbursement Data

Sign up for Laura Luebke — Billing Profile & Reimbursement Data policy alerts

Laura Luebke — Billing Profile & Reimbursement Data

Sign up for Laura Luebke — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Frequently Asked Questions

References